Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-042058
Filing Date
2017-08-10
Accepted
2017-08-10 16:16:40
Documents
45
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v472178_10q.htm 10-Q 211102
2 EXHIBIT 31.1 v472178_ex31-1.htm EX-31.1 12279
3 EXHIBIT 31.2 v472178_ex31-2.htm EX-31.2 12481
4 EXHIBIT 32.1 v472178_ex32-1.htm EX-32.1 5180
5 EXHIBIT 32.2 v472178_ex32-2.htm EX-32.2 5261
  Complete submission text file 0001144204-17-042058.txt   1419195

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20170630.xml EX-101.INS 183251
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20170630.xsd EX-101.SCH 22594
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20170630_cal.xml EX-101.CAL 13235
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20170630_def.xml EX-101.DEF 109884
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20170630_lab.xml EX-101.LAB 135902
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20170630_pre.xml EX-101.PRE 130592
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 171021654
SIC: 2836 Biological Products, (No Diagnostic Substances)